{"pmid":32348495,"pmcid":"PMC7197559","title":"Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with disease severity in COVID-19.","text":["Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with disease severity in COVID-19.","A major unanswered question in the current global COVID-19 outbreak is why a small minority of infected individuals develop severe disease. Here we report that homozygosity for the C allele of rs12252 in the interferon-induced transmembrane protein 3 (IFITM3) gene is associated with more severe disease in an age dependent manner. This supports a role for IFITM3 in disease pathogenesis and the opportunity for early targeted intervention in at risk individuals.","J Infect Dis","Zhang, Yonghong","Qin, Ling","Zhao, Yan","Zhang, Ping","Xu, Bin","Li, Kang","Liang, Lianchun","Zhang, Chi","Dai, Yanchao","Feng, Yingmei","Sun, Jianping","Hu, Zhongjie","Xiang, Haiping","Knight, Julian C","Dong, Tao","Jin, Ronghua","32348495"],"abstract":["A major unanswered question in the current global COVID-19 outbreak is why a small minority of infected individuals develop severe disease. Here we report that homozygosity for the C allele of rs12252 in the interferon-induced transmembrane protein 3 (IFITM3) gene is associated with more severe disease in an age dependent manner. This supports a role for IFITM3 in disease pathogenesis and the opportunity for early targeted intervention in at risk individuals."],"journal":"J Infect Dis","authors":["Zhang, Yonghong","Qin, Ling","Zhao, Yan","Zhang, Ping","Xu, Bin","Li, Kang","Liang, Lianchun","Zhang, Chi","Dai, Yanchao","Feng, Yingmei","Sun, Jianping","Hu, Zhongjie","Xiang, Haiping","Knight, Julian C","Dong, Tao","Jin, Ronghua"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32348495","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1093/infdis/jiaa224","topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138495387697152,"score":9.490897,"similar":[{"pmid":32413319,"title":"SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues.","text":["SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues.","There is pressing urgency to understand the pathogenesis of the severe acute respiratory syndrome coronavirus clade 2 (SARS-CoV-2), which causes the disease COVID-19. SARS-CoV-2 spike (S) protein binds angiotensin-converting enzyme 2 (ACE2), and in concert with host proteases, principally transmembrane serine protease 2 (TMPRSS2), promotes cellular entry. The cell subsets targeted by SARS-CoV-2 in host tissues and the factors that regulate ACE2 expression remain unknown. Here, we leverage human, non-human primate, and mouse single-cell RNA-sequencing (scRNA-seq) datasets across health and disease to uncover putative targets of SARS-CoV-2 among tissue-resident cell subsets. We identify ACE2 and TMPRSS2 co-expressing cells within lung type II pneumocytes, ileal absorptive enterocytes, and nasal goblet secretory cells. Strikingly, we discovered that ACE2 is a human interferon-stimulated gene (ISG) in vitro using airway epithelial cells and extend our findings to in vivo viral infections. Our data suggest that SARS-CoV-2 could exploit species-specific interferon-driven upregulation of ACE2, a tissue-protective mediator during lung injury, to enhance infection.","Cell","Ziegler, Carly G K","Allon, Samuel J","Nyquist, Sarah K","Mbano, Ian M","Miao, Vincent N","Tzouanas, Constantine N","Cao, Yuming","Yousif, Ashraf S","Bals, Julia","Hauser, Blake M","Feldman, Jared","Muus, Christoph","Wadsworth, Marc H 2nd","Kazer, Samuel W","Hughes, Travis K","Doran, Benjamin","Gatter, G James","Vukovic, Marko","Taliaferro, Faith","Mead, Benjamin E","Guo, Zhiru","Wang, Jennifer P","Gras, Delphine","Plaisant, Magali","Ansari, Meshal","Angelidis, Ilias","Adler, Heiko","Sucre, Jennifer M S","Taylor, Chase J","Lin, Brian","Waghray, Avinash","Mitsialis, Vanessa","Dwyer, Daniel F","Buchheit, Kathleen M","Boyce, Joshua A","Barrett, Nora A","Laidlaw, Tanya M","Carroll, Shaina L","Colonna, Lucrezia","Tkachev, Victor","Peterson, Christopher W","Yu, Alison","Zheng, Hengqi Betty","Gideon, Hannah P","Winchell, Caylin G","Lin, Philana Ling","Bingle, Colin D","Snapper, Scott B","Kropski, Jonathan A","Theis, Fabian J","Schiller, Herbert B","Zaragosi, Laure-Emmanuelle","Barbry, Pascal","Leslie, Alasdair","Kiem, Hans-Peter","Flynn, JoAnne L","Fortune, Sarah M","Berger, Bonnie","Finberg, Robert W","Kean, Leslie S","Garber, Manuel","Schmidt, Aaron G","Lingwood, Daniel","Shalek, Alex K","Ordovas-Montanes, Jose","32413319"],"abstract":["There is pressing urgency to understand the pathogenesis of the severe acute respiratory syndrome coronavirus clade 2 (SARS-CoV-2), which causes the disease COVID-19. SARS-CoV-2 spike (S) protein binds angiotensin-converting enzyme 2 (ACE2), and in concert with host proteases, principally transmembrane serine protease 2 (TMPRSS2), promotes cellular entry. The cell subsets targeted by SARS-CoV-2 in host tissues and the factors that regulate ACE2 expression remain unknown. Here, we leverage human, non-human primate, and mouse single-cell RNA-sequencing (scRNA-seq) datasets across health and disease to uncover putative targets of SARS-CoV-2 among tissue-resident cell subsets. We identify ACE2 and TMPRSS2 co-expressing cells within lung type II pneumocytes, ileal absorptive enterocytes, and nasal goblet secretory cells. Strikingly, we discovered that ACE2 is a human interferon-stimulated gene (ISG) in vitro using airway epithelial cells and extend our findings to in vivo viral infections. Our data suggest that SARS-CoV-2 could exploit species-specific interferon-driven upregulation of ACE2, a tissue-protective mediator during lung injury, to enhance infection."],"journal":"Cell","authors":["Ziegler, Carly G K","Allon, Samuel J","Nyquist, Sarah K","Mbano, Ian M","Miao, Vincent N","Tzouanas, Constantine N","Cao, Yuming","Yousif, Ashraf S","Bals, Julia","Hauser, Blake M","Feldman, Jared","Muus, Christoph","Wadsworth, Marc H 2nd","Kazer, Samuel W","Hughes, Travis K","Doran, Benjamin","Gatter, G James","Vukovic, Marko","Taliaferro, Faith","Mead, Benjamin E","Guo, Zhiru","Wang, Jennifer P","Gras, Delphine","Plaisant, Magali","Ansari, Meshal","Angelidis, Ilias","Adler, Heiko","Sucre, Jennifer M S","Taylor, Chase J","Lin, Brian","Waghray, Avinash","Mitsialis, Vanessa","Dwyer, Daniel F","Buchheit, Kathleen M","Boyce, Joshua A","Barrett, Nora A","Laidlaw, Tanya M","Carroll, Shaina L","Colonna, Lucrezia","Tkachev, Victor","Peterson, Christopher W","Yu, Alison","Zheng, Hengqi Betty","Gideon, Hannah P","Winchell, Caylin G","Lin, Philana Ling","Bingle, Colin D","Snapper, Scott B","Kropski, Jonathan A","Theis, Fabian J","Schiller, Herbert B","Zaragosi, Laure-Emmanuelle","Barbry, Pascal","Leslie, Alasdair","Kiem, Hans-Peter","Flynn, JoAnne L","Fortune, Sarah M","Berger, Bonnie","Finberg, Robert W","Kean, Leslie S","Garber, Manuel","Schmidt, Aaron G","Lingwood, Daniel","Shalek, Alex K","Ordovas-Montanes, Jose"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32413319","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.cell.2020.04.035","keywords":["ace2","covid-19","isg","sars-cov-2","human","influenza","interferon","mouse","non-human primate","scrna-seq"],"locations":["Tissues"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666897319120863233,"score":130.0061},{"pmid":32492195,"title":"Functional prediction and frequency of coding variants in human ACE2 at binding sites with SARS-CoV-2 spike protein on different populations.","text":["Functional prediction and frequency of coding variants in human ACE2 at binding sites with SARS-CoV-2 spike protein on different populations.","Hussain et al.(1) identified 17 natural coding variants for human angiotensin-converting enzyme 2 (ACE2) that were found at important positions for binding of ACE2 with SARS-CoV-2 spike protein(1) . They suggested that positive prognosis of COVID-19 may be due to the existence of ACE2 variants like rs73635825 and rs143936283 in some individuals, and to screen frequencies of candidate alleles in different populations to predict the prognosis of COVID-19(1) . We contributed with further data for these 17 ACE2 variants using other function prediction tools. Moreover, we searched for the minor allele frequency (MAF) for these ACE2 variants as reported in different populations and debated regarding their use in population genetic studies. This article is protected by copyright. All rights reserved.","J Med Virol","Cruz, Juliana de O","Conceicao, Izabela M C A","Sousa, Sandra Mara B","Luizon, Marcelo R","32492195"],"abstract":["Hussain et al.(1) identified 17 natural coding variants for human angiotensin-converting enzyme 2 (ACE2) that were found at important positions for binding of ACE2 with SARS-CoV-2 spike protein(1) . They suggested that positive prognosis of COVID-19 may be due to the existence of ACE2 variants like rs73635825 and rs143936283 in some individuals, and to screen frequencies of candidate alleles in different populations to predict the prognosis of COVID-19(1) . We contributed with further data for these 17 ACE2 variants using other function prediction tools. Moreover, we searched for the minor allele frequency (MAF) for these ACE2 variants as reported in different populations and debated regarding their use in population genetic studies. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Cruz, Juliana de O","Conceicao, Izabela M C A","Sousa, Sandra Mara B","Luizon, Marcelo R"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32492195","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1002/jmv.26126","keywords":["ace2","genetic variation","missense mutation","receptor binding","sars-cov-2"],"topics":["Mechanism"],"weight":1,"_version_":1668892169437446145,"score":128.16315},{"pmid":32188729,"title":"Coronavirus Endoribonuclease and Deubiquitinating Interferon Antagonists Differentially Modulate the Host Response during Replication in Macrophages.","text":["Coronavirus Endoribonuclease and Deubiquitinating Interferon Antagonists Differentially Modulate the Host Response during Replication in Macrophages.","Coronaviruses encode multiple interferon antagonists that modulate the host response to virus replication. Here, we evaluated the host transcriptional response to infection with murine coronaviruses encoding independent mutations in one of two different viral antagonists: the deubiquitinase (DUB) within nonstructural protein 3 or the endoribonuclease (EndoU) within nonstructural protein 15. We used transcriptomics approaches to compare the scope and kinetics of the host response to the wild-type, DUBmut, and EndoUmut viruses in infected macrophages. We found that the EndoUmut virus activates a focused response predominantly involving type I interferons and interferon-related genes, whereas the WT and DUBmut viruses more broadly stimulate upregulation of over 2,800 genes, including networks associated with activating the unfolded protein response (UPR), and the proinflammatory response associated with viral pathogenesis. This study highlights the role of viral interferon antagonists in shaping the kinetics and magnitude of the host response during virus infection and demonstrates that inactivating a dominant viral antagonist, the coronavirus endoribonuclease, dramatically alters the host response in macrophages.ImportanceMacrophages are an important cell type during coronavirus infections because they \"notice\" the infection and respond by inducing type I interferons, which limits virus replication. In turn, coronaviruses encode proteins that mitigate the cell's ability to signal an interferon response. Here, we evaluated the host macrophage response to two independent mutant coronaviruses: one with reduced deubiquitinating activity (DUBmut) and the other containing an inactivated endoribonuclease (EndoUmut). We observed a rapid, robust, and focused response to the EndoUmut virus, which was characterized by enhanced expression of interferon and interferon-related genes. In contrast, wild-type virus and the DUBmut virus elicited a more limited interferon response and ultimately activated over 2,800 genes, including players in the unfolded protein response and pro-inflammatory pathways associated with progression of significant disease. This study reveals that EndoU activity substantially contributes to the ability of coronaviruses to evade the host innate response and to replicate in macrophages.","J Virol","Volk, Aaron","Hackbart, Matthew","Deng, Xufang","Cruz-Pulido, Yazmin","O'Brien, Amornrat","Baker, Susan C","32188729"],"abstract":["Coronaviruses encode multiple interferon antagonists that modulate the host response to virus replication. Here, we evaluated the host transcriptional response to infection with murine coronaviruses encoding independent mutations in one of two different viral antagonists: the deubiquitinase (DUB) within nonstructural protein 3 or the endoribonuclease (EndoU) within nonstructural protein 15. We used transcriptomics approaches to compare the scope and kinetics of the host response to the wild-type, DUBmut, and EndoUmut viruses in infected macrophages. We found that the EndoUmut virus activates a focused response predominantly involving type I interferons and interferon-related genes, whereas the WT and DUBmut viruses more broadly stimulate upregulation of over 2,800 genes, including networks associated with activating the unfolded protein response (UPR), and the proinflammatory response associated with viral pathogenesis. This study highlights the role of viral interferon antagonists in shaping the kinetics and magnitude of the host response during virus infection and demonstrates that inactivating a dominant viral antagonist, the coronavirus endoribonuclease, dramatically alters the host response in macrophages.ImportanceMacrophages are an important cell type during coronavirus infections because they \"notice\" the infection and respond by inducing type I interferons, which limits virus replication. In turn, coronaviruses encode proteins that mitigate the cell's ability to signal an interferon response. Here, we evaluated the host macrophage response to two independent mutant coronaviruses: one with reduced deubiquitinating activity (DUBmut) and the other containing an inactivated endoribonuclease (EndoUmut). We observed a rapid, robust, and focused response to the EndoUmut virus, which was characterized by enhanced expression of interferon and interferon-related genes. In contrast, wild-type virus and the DUBmut virus elicited a more limited interferon response and ultimately activated over 2,800 genes, including players in the unfolded protein response and pro-inflammatory pathways associated with progression of significant disease. This study reveals that EndoU activity substantially contributes to the ability of coronaviruses to evade the host innate response and to replicate in macrophages."],"journal":"J Virol","authors":["Volk, Aaron","Hackbart, Matthew","Deng, Xufang","Cruz-Pulido, Yazmin","O'Brien, Amornrat","Baker, Susan C"],"date":"2020-03-20T11:00:00Z","year":2020,"_id":"32188729","source":"PubMed","week":"202012|Mar 16 - Mar 22","doi":"10.1128/JVI.00178-20","topics":["Mechanism"],"weight":1,"_version_":1666138490572636160,"score":124.54053},{"pmid":32461321,"title":"Porcine epidemic diarrhea virus deficient in RNA cap guanine-N-7 methylation is attenuated and induces higher type I and III interferon responses.","text":["Porcine epidemic diarrhea virus deficient in RNA cap guanine-N-7 methylation is attenuated and induces higher type I and III interferon responses.","The 5' cap methylation of viral RNA plays an important role in RNA stability, efficient translation, and immune evasion. Thus, RNA cap methylation is an attractive target for antiviral discovery and development of new live attenuated vaccines. For coronaviruses, RNA cap structure is first methylated at guanine N-7 (G-N-7) position by nonstructural protein 14 (nsp14), which facilitates and precedes the subsequent ribose 2'-O methylation by nsp16-nsp10 complex. Using porcine epidemic diarrhea virus (PEDV), an Alphacoronavirus, as a model, we showed that G-N-7 methyltransferase (G-N-7 MTase) of PEDV nsp14 methylated RNA substrates in a sequence-unspecific manner. PEDV nsp14 can efficiently methylate RNA substrates with various lengths in both neutral and alkaline pH environment, and can methylate cap analogs (GpppA and GpppG) and single nucleotide GTP but not ATP, CTP, or UTP. Mutations to the S-adenosyl-L-methionine (SAM) binding motif in the nsp14 abolished the G-N-7 MTase activity and were lethal to PEDV. However, recombinant rPEDV-D350A with a single mutation (D350A) in nsp14, which retained 29.0% of G-N-7 MTase activity, was viable. Recombinant rPEDV-D350A formed significantly smaller plaque and had significant defects in viral protein synthesis and viral replication in Vero CCL-81 cells and intestinal porcine epithelial cells (IPEC-DQ) cells. Notably, rPEDV-D350A induced significantly higher expression of both type I and III interferons in IPEC-DQ cells compared to the parental rPEDV. Collectively, our results demonstrate that G-N-7 MTase activity of PEDV modulates viral replication, gene expression, and innate immune responses.IMPORTANCE Coronaviruses (CoVs) include a wide range of important human and animal pathogens. Examples of human CoVs include severe acute respiratory syndrome coronavirus (SARS-CoV-1), Middle East respiratory syndrome coronavirus (MERS-CoV), and the most recently emerged SARS-CoV-2. Examples of pig CoVs include porcine epidemic diarrhea virus (PEDV), porcine deltacoronavirus (PDCoV), and swine enteric alphacoronavirus (SeACoV). There are no vaccines or antiviral drugs for most of these viruses. All known CoVs encode a bifunctional nsp14 protein which possesses ExoN and G-N-7 MTase activities, responsible for replication fidelity and RNA cap G-N-7 methylation, respectively. Here, we biochemically characterized G-N-7 MTase of PEDV nsp14 and found that G-N-7 MTase-deficient PEDV was defective in replication and induced higher type I and III interferons. These findings highlight that CoV G-N-7 MTase may be a novel target for rational design of live attenuated vaccines and antiviral drugs.","J Virol","Lu, Yunjian","Cai, Hui","Lu, Mijia","Ma, Yuanmei","Li, Anzhong","Gao, Youling","Zhou, Jiyong","Gu, Howard","Li, Jianrong","Gu, Jinyan","32461321"],"abstract":["The 5' cap methylation of viral RNA plays an important role in RNA stability, efficient translation, and immune evasion. Thus, RNA cap methylation is an attractive target for antiviral discovery and development of new live attenuated vaccines. For coronaviruses, RNA cap structure is first methylated at guanine N-7 (G-N-7) position by nonstructural protein 14 (nsp14), which facilitates and precedes the subsequent ribose 2'-O methylation by nsp16-nsp10 complex. Using porcine epidemic diarrhea virus (PEDV), an Alphacoronavirus, as a model, we showed that G-N-7 methyltransferase (G-N-7 MTase) of PEDV nsp14 methylated RNA substrates in a sequence-unspecific manner. PEDV nsp14 can efficiently methylate RNA substrates with various lengths in both neutral and alkaline pH environment, and can methylate cap analogs (GpppA and GpppG) and single nucleotide GTP but not ATP, CTP, or UTP. Mutations to the S-adenosyl-L-methionine (SAM) binding motif in the nsp14 abolished the G-N-7 MTase activity and were lethal to PEDV. However, recombinant rPEDV-D350A with a single mutation (D350A) in nsp14, which retained 29.0% of G-N-7 MTase activity, was viable. Recombinant rPEDV-D350A formed significantly smaller plaque and had significant defects in viral protein synthesis and viral replication in Vero CCL-81 cells and intestinal porcine epithelial cells (IPEC-DQ) cells. Notably, rPEDV-D350A induced significantly higher expression of both type I and III interferons in IPEC-DQ cells compared to the parental rPEDV. Collectively, our results demonstrate that G-N-7 MTase activity of PEDV modulates viral replication, gene expression, and innate immune responses.IMPORTANCE Coronaviruses (CoVs) include a wide range of important human and animal pathogens. Examples of human CoVs include severe acute respiratory syndrome coronavirus (SARS-CoV-1), Middle East respiratory syndrome coronavirus (MERS-CoV), and the most recently emerged SARS-CoV-2. Examples of pig CoVs include porcine epidemic diarrhea virus (PEDV), porcine deltacoronavirus (PDCoV), and swine enteric alphacoronavirus (SeACoV). There are no vaccines or antiviral drugs for most of these viruses. All known CoVs encode a bifunctional nsp14 protein which possesses ExoN and G-N-7 MTase activities, responsible for replication fidelity and RNA cap G-N-7 methylation, respectively. Here, we biochemically characterized G-N-7 MTase of PEDV nsp14 and found that G-N-7 MTase-deficient PEDV was defective in replication and induced higher type I and III interferons. These findings highlight that CoV G-N-7 MTase may be a novel target for rational design of live attenuated vaccines and antiviral drugs."],"journal":"J Virol","authors":["Lu, Yunjian","Cai, Hui","Lu, Mijia","Ma, Yuanmei","Li, Anzhong","Gao, Youling","Zhou, Jiyong","Gu, Howard","Li, Jianrong","Gu, Jinyan"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32461321","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1128/JVI.00447-20","e_drugs":["Uridine Triphosphate","Nitrogen","Adenosine Triphosphate","Guanosine Triphosphate","Cytidine Triphosphate","S-Adenosylmethionine","Ribose"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1668079521552662529,"score":121.45451},{"pmid":32442315,"title":"Alternative splicing of ACE2 possibly generates variants that may limit the entry of SARS-CoV-2: a potential therapeutic approach using SSOs.","text":["Alternative splicing of ACE2 possibly generates variants that may limit the entry of SARS-CoV-2: a potential therapeutic approach using SSOs.","Angiotensin-converting enzyme 2 (ACE2) plays an essential role in maintaining the balance of the renin-angiotensin system and also serves as a receptor for the SARS-CoV-2, SARS-CoV, and HCoV-NL63. Following the recent outbreak of SARS-CoV-2 infection, there has been an urgent need to develop therapeutic interventions. ACE2 is a potential target for many treatment approaches for the SARS-CoV-2. With the help of bioinformatics, we have predicted several novel exons of the human ACE2 gene. The inclusion of novel exons located in the 5'UTR/intronic region in the mature transcript may remove the critical ACE2 residues responsible for the interaction with the receptor-binding domain (RBD) of SARS-CoV-2, thus preventing their binding and entry into the cell. Additionally, inclusion of a novel predicted exons located in the 3'UTR by alternative splicing may remove the C-terminal transmembrane domain of ACE2 and generate soluble ACE2 isoforms. Splice-switching antisense oligonucleotides (SSOs) have been employed effectively as a therapeutic strategy in several disease conditions. Alternative splicing of the ACE2 gene could similarly be modulated using SSOs to exclude critical domains required for the entry of SARS-CoV-2. Strategies can also be designed to deliver these SSOs directly to the lungs in order to minimize the damage caused by SARS-CoV-2 pathogenesis.","Clin Sci (Lond)","Rehman, Sayeed Ur","Tabish, Mohammad","32442315"],"abstract":["Angiotensin-converting enzyme 2 (ACE2) plays an essential role in maintaining the balance of the renin-angiotensin system and also serves as a receptor for the SARS-CoV-2, SARS-CoV, and HCoV-NL63. Following the recent outbreak of SARS-CoV-2 infection, there has been an urgent need to develop therapeutic interventions. ACE2 is a potential target for many treatment approaches for the SARS-CoV-2. With the help of bioinformatics, we have predicted several novel exons of the human ACE2 gene. The inclusion of novel exons located in the 5'UTR/intronic region in the mature transcript may remove the critical ACE2 residues responsible for the interaction with the receptor-binding domain (RBD) of SARS-CoV-2, thus preventing their binding and entry into the cell. Additionally, inclusion of a novel predicted exons located in the 3'UTR by alternative splicing may remove the C-terminal transmembrane domain of ACE2 and generate soluble ACE2 isoforms. Splice-switching antisense oligonucleotides (SSOs) have been employed effectively as a therapeutic strategy in several disease conditions. Alternative splicing of the ACE2 gene could similarly be modulated using SSOs to exclude critical domains required for the entry of SARS-CoV-2. Strategies can also be designed to deliver these SSOs directly to the lungs in order to minimize the damage caused by SARS-CoV-2 pathogenesis."],"journal":"Clin Sci (Lond)","authors":["Rehman, Sayeed Ur","Tabish, Mohammad"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32442315","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1042/CS20200419","keywords":["sars-cov-2","alternative splicing","angiotensin-converting enzyme 2 (ace2)","splice-switching oligos"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1667535119565455362,"score":119.39148}]}